company background image
002118 logo

Jilin Zixin Pharmaceutical IndustrialLtd SZSE:002118 Stock Report

Last Price

CN¥0.37

Market Cap

CN¥473.9m

7D

0%

1Y

-85.4%

Updated

05 Aug, 2023

Data

Company Financials

Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

SZSE:002118 Stock Report

Market Cap: CN¥473.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

002118 Stock Overview

Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China. More details

002118 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Jilin Zixin Pharmaceutical IndustrialLtd
Historical stock prices
Current Share PriceCN¥0.37
52 Week HighCN¥2.98
52 Week LowCN¥0.37
Beta0.46
1 Month Change0%
3 Month Change-76.88%
1 Year Change-85.43%
3 Year Change-92.04%
5 Year Change-93.32%
Change since IPO-73.04%

Recent News & Updates

Recent updates

Shareholder Returns

002118CN PharmaceuticalsCN Market
7D0%-3.3%-1.1%
1Y-85.4%-8.1%4.2%

Return vs Industry: 002118 underperformed the CN Pharmaceuticals industry which returned -1.6% over the past year.

Return vs Market: 002118 underperformed the CN Market which returned -4.4% over the past year.

Price Volatility

Is 002118's price volatile compared to industry and market?
002118 volatility
002118 Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement7.2%
10% most volatile stocks in CN Market11.2%
10% least volatile stocks in CN Market4.3%

Stable Share Price: 002118's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 002118's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1998842Youshun Fengwww.jilinzixin.com.cn

Jilin Zixin Pharmaceutical Industrial Co.,Ltd researches, develops, produces, and sells Chinese medicines and gene sequencers in China. It provides ginseng drugs, prescription drugs, and OTC drugs. The company offers its products in the form of pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, and lozenges.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Fundamentals Summary

How do Jilin Zixin Pharmaceutical IndustrialLtd's earnings and revenue compare to its market cap?
002118 fundamental statistics
Market capCN¥473.88m
Earnings (TTM)-CN¥1.19b
Revenue (TTM)CN¥149.92m

3.2x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002118 income statement (TTM)
RevenueCN¥149.92m
Cost of RevenueCN¥63.88m
Gross ProfitCN¥86.04m
Other ExpensesCN¥1.28b
Earnings-CN¥1.19b

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Aug 23, 2023

Earnings per share (EPS)-0.93
Gross Margin57.39%
Net Profit Margin-793.41%
Debt/Equity Ratio497.1%

How did 002118 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/05 18:43
End of Day Share Price 2023/06/15 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
YANG QIAOChangjiang Securities Co. LTD.
Qiu Han HuangSealand Securities